Charlotte’s Web Holdings (OTCQX: CWBHF), a pioneer in hemp-derived CBD products, announced the completion of an audit of its 2019 hemp harvest, which is the primary source of its full spectrum extracts. The Company grows 100 percent of its Hemp in its American facilities located...
Baudax Bio (NASDAQ: BXRX), a pharmaceutical Company developing novel therapeutics for Acute Care Settings, announed the approval of a New Drug Application ( NDA) for ANJESO (meloxicam injection), intended for alleviating moderate to severe pain, either as a standalone treatment or in combination with other...
Kannalife Inc (OTCQB: KLFE), a biopharmaceutical Company developing CBD-based therapeutics for the treatment of neurodegenerative and neuropathic pain disorders, announced the grant of a patent Chinese Patent CN106456573B specific to "Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy",...
Cannabics Pharmaceuticals (OTCQB: CNBX), an early-stage Biotechnology Company focussed on creating cannabinoid-based therapeutics and therapies for treatment of cancer, announced the signing of a Memorandum of Understanding (MoU) with RCK Medical Cannabis, an Israeli cannabis company that creates tailor-made medical cannabis strains and hybrid seeds...
Cure Pharmaceutical (OTCQB: CURR), a Company leveraging its proprietary drug dosage forms and delivery systems to create innovative therapeutics in collaboration with leading biotech and pharmaceutical companies, announced the signing of an exclusive licensing agreement with ReLeaf Europe, a leading European Medicinal Cannabis Company. ReLeaf...
Valens GroWorks Corp (OTCQX: VGWCF), a vertically-integrated cannabis player providing extraction products and services, announced the signing of an amended manufacturing and sales licence agreement with SōRSE Technology Corporation for use of its proprietary SōRSE emulsion technology to produce, sell and distribute cannabis-infused products. SōRSE...
MedPharm set to launch First-of-Its kind Cannabis-based Clinical Trial in Alzheimer MedPharm Holdings, an acquisition target of Medicine Man Technologies (OTCQX: MDCL), is all set to launch a landmark, double-blind, placebo controlled clinical trial which will evaluate the effect of cannabis on patients with Dementia and...
CV Sciences (OTCQB: CVSI), the manufacturer of PLUSCBD range of hemp-based CBD oils, the #1 selling hemp CBD supplement in North America, announced the signing of a new distribution agreement with Southeastern Grocers, Inc. The agreement will enable the Company to launch its PlusCBD oil...
Medicinova (NASDAQ: MNOV), a Company developing small molecule therapeutics, has received notice of allowances for grant of new patents for MN-166 (ibudilast) for the treatment of amyotrophic lateral sclerosis (ALS) from the Canadian Intellectual Property Office, in addition to receiving a Notice of Allowance for...
The Cannabis plant has an estimated 113 different compounds, out of which THC and CBD are the two main constituents. These affect the receptors in the brain to alter an individual’s physical and mental state. THC is mainly responsible for the psychoactive effects or the...
